The study revealed that these two mechanisms correspond to key malignant phenotypes of osteosarcoma: dysregulation of FNDC3B directly promotes epithelial-mesenchymal transition (EMT) and metastatic potential, whereas overexpression of ZMIZ1 drives uncontrolled cell cycle dynamics and resistance to apoptosis. This evidence concerns the gene FNDC3B and osteosarcoma.